May 2 |
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates
|
May 2 |
Relay Therapeutics GAAP EPS of -$0.62 beats by $0.08, revenue of $10M beats by $9.89M
|
May 2 |
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
|
Apr 25 |
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
|
Apr 11 |
Relay Therapeutics to Participate in Upcoming Investor Conferences
|
Mar 17 |
11 Oversold Biotech Stocks To Buy Right Now
|
Mar 15 |
3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise
|
Mar 13 |
Does Relay Therapeutics, Inc. (RLAY) Have the Potential to Rally 146.52% as Wall Street Analysts Expect?
|
Mar 13 |
Relay Therapeutics: Platform More Important Than Programs
|
Feb 26 |
Relay Therapeutics to Participate in Three Upcoming Investor Conferences
|